Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
IL-4 induces M2 macrophages to produce sustained analgesia via opioids
Melih Ö. Celik, … , Rainer Glauben, Halina Machelska
Melih Ö. Celik, … , Rainer Glauben, Halina Machelska
Published February 27, 2020
Citation Information: JCI Insight. 2020;5(4):e133093. https://doi.org/10.1172/jci.insight.133093.
View: Text | PDF
Research Article Neuroscience

IL-4 induces M2 macrophages to produce sustained analgesia via opioids

  • Text
  • PDF
Abstract

IL-4 is a pleiotropic antiinflammatory cytokine, which can be neuroprotective after nervous system injury. The beneficial actions of IL-4 are thought to result from the blunting of action of inflammatory mediators, such as proinflammatory cytokines. Here, we demonstrate that IL-4 induces M2 macrophages to continuously produce opioid peptides and ameliorate pain. IL-4 application at injured nerves in mice shifted F4/80+ macrophages from the proinflammatory M1 to the antiinflammatory M2 phenotype, which synthesized opioid peptides (Met-enkephalin, β-endorphin, and dynorphin A 1-17). These effects were accompanied by a long-lasting attenuation of neuropathy-induced mechanical hypersensitivity, beyond the IL-4 treatment. This IL-4-induced analgesia was decreased by opioid peptide antibodies and opioid receptor (δ, μ, κ) antagonists applied at injured nerves, which confirms the involvement of the local opioid system. The participation of M2 macrophages was supported by analgesia in recipient mice injected at injured nerves with F4/80+ macrophages from IL-4–treated donors. Together, IL-4–induced M2 macrophages at injured nerves produced opioid peptides, which activated peripheral opioid receptors to diminish pain. Fostering the opioid-mediated actions of intrinsic M2 macrophages may be a strategy to tackle pathological pain.

Authors

Melih Ö. Celik, Dominika Labuz, Jacqueline Keye, Rainer Glauben, Halina Machelska

×

Figure 3

Injured nerves are infiltrated by proinflammatory M1 macrophages.

Options: View larger image (or click on image) Download as PowerPoint
Injured nerves are infiltrated by proinflammatory M1 macrophages.
Quanti...
Quantitative mRNA expression of M1 markers (Il-1β, Tnf, iNos) and M2 markers (Il-10, Arg-1, Ym1) in F4/80+ macrophages isolated by IMS from injured nerves of control animals (24 hours after the last vehicle injection at the chronic constriction injury [CCI] site) on day 22 after CCI. **P < 0.01, ***P < 0.001 represent a significant difference between the respective M1 marker and each M2 marker; 1-way repeated-measures ANOVA and Bonferroni’s test. Data were acquired by qRT-PCR, represent relative mRNA expression levels normalized to Gapdh, are expressed as fold change vs. Ym1, and are shown as individual data points and mean ± SEM. n = 8 samples per group.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts